Browsing Faculty of Health and Life Sciences by Author "Jones, AG"

Now showing items 1-16 of 16

    Issue DateTitleAuthor(s)
    21 February 2023Age of diagnosis does not alter the presentation or progression of robustly defined adult onset type 1 diabetes  Thomas, NJ; Hill, AV; Dayan, CM; et al.
    22 January 2024Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study  Jones, AG; Shields, BM; Oram, RA; et al.
    16 June 2023Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: An application for type 2 diabetes precision medicine  Venkatasubramaniam, A; Mateen, BA; Shields, BM; et al.
    21 April 2022Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study  Niwaha, AJ; Rodgers, LR; Carr, ALJ; et al.
    14 November 2022Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study  Dennis, JM; Young, KG; McGovern, AP; et al.
    6 May 2022Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium  Tatovic, D; Jones, AG; Evans, C; et al.
    22 November 2022The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis  Young, KG; McGovern, AP; Barroso, I; et al.
    18 April 2022Is glycaemic control associated with dietary patterns independent of weight change in people newly diagnosed with type 2 diabetes? Prospective analysis of the Early-ACTivity-In-Diabetes trial  Garbutt, J; England, C; Jones, AG; et al.
    20 January 2022Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: The case study of the Changing Diabetes in Children program in Cameroon.  Katte, JC; Lemdjo, G; Dehayem, MY; et al.
    7 December 2022Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study  Shields, BM; Angwin, CD; Shepherd, MH; et al.
    7 December 2022Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study  Shields, BM; Dennis, JM; Angwin, CD; et al.
    27 January 2023The phenotype of type 1 diabetes in sub-Saharan Africa  Katte, JC; McDonald, TJ; Sobngwi, E; et al.
    22 February 2024Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes  Cardoso, P; Young, KG; Nair, ATN; et al.
    7 October 2022Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation  Eason, RJ; Thomas, NJ; Hill, AV; et al.
    5 June 2024Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach  Güdemann, LM; Young, KG; Thomas, NJM; et al.
    9 February 2022Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes  Kibirige, D; Sekitoleko, I; Lumu, W; et al.